Metsera brings its portfolio of experimental obesity drugs, with MET-097i, a GLP-1 injectable, and MET-233i, which mimics the pancreatic hormone amylin, being the key among them. MET-233i is being ...
(Reuters) -Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up to $7.3 billion, including future payments, as it seeks to gain a foothold in the fast-growing obesity ...
FF14 7.35 has just been revealed in full, courtesy of a special stage from game director Naoki Yoshida and community producer Toshio Murouchi at Tokyo Games Show. The event, which was live streamed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback